Nitric oxide in the nervous system

Annual Review of Pharmacology and Toxicology

Volumn 35, Issue , 1995, Pages 213-233

  Zhang, J ^a,b   Snyder, S H ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

cytochrome P450; endothelial derived relaxing factor; heme; long term potentiation; penile erection

Indexed keywords

ARGININE; CITRULLINE; CYCLOSPORIN A; ENDOTHELIUM DERIVED RELAXING FACTOR; ISOENZYME; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) METHYLARGININE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TACROLIMUS;

BIOSYNTHESIS; BLOOD VESSEL; BRAIN; HUMAN; MACROPHAGE; NERVE CELL LESION; NERVOUS SYSTEM; NEUROTOXICITY; NEUROTRANSMISSION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROKE;

EID: 0028987868     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pa.35.040195.001241     Document Type: Review

References (150)

1. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. 1993. Carbon monoxide, a putative neural messenger. Science 259:381-84
2. Ewing JF, Maines MD. 1992. In situ hybridization and immunohistochemical localization of heme oxygenase-2 mRNA and protein in normal rat brain: differential distribution of isozyme 1 and 2. Mol. Cell Neurosci. 3:559-70
3. Green LC, Ruiz-de-Luzuriaga K, Wagner DA, Rand W, Istfan N, et al. 1981. Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. USA 78:7764-68
4. Green LC, Tannenbaum SR, Goldman P. 1981. Nitrate synthesis in the germtree and conventional rat. Science 212: 56-58
5. Hibbs JB Jr, Tainlor RR, Vavrin Z. 1987. Macrophage cytotoxicity: role for L-arginine deaminase and imino nitrogen oxidation to nitrite. Science 235:473-76
6. Stuehr DJ, Gross SS, Sukuma I, Levi R, Nathan CF. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169:1011-20
7. Arnold WP, Mittal CK, Katsuki S, Murad F. 1977. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. USA 74:3203-7
8. Ignarro LJ, Lippton H, Edwards .JC, Baricos WH, Hyman AL, et al. 1981. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218:739-49
9. Furchgott RF, Zawadzki JV. 1980. The obligatory role of endothelial cells in the relaxation ot arterial smooth muscle by acelylcholine. Nature 288:373-76
10. Ignarro LJ, Buga GM. Wood KS, Byrns RE, Chaudhuri G. 1987. Endotheliumderived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84: 9265-69
11. Palmer RMJ, Ferrige AC, Moncada S. 1987. Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature 327:524-26
12. Garthwaite J, Charles SL, Chess-Williams R. 1988. Endothelium-denved relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-88
13. Bredt DS, Snyder SH. 1989. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86:9030-33
14. Garthwaite J, Garthwaite G, Palmer RMJ, Moncada S. 1989. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Ear. J. Pharmac. 172:413-16
15. Bredt DS, Snyder SH. 1994. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63:175-95
16. Bredt DS, Snyder SH. 1990. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87:682-85
17. Bredt DS, Hwang PH, Glatt C, Lowenstein C, Reed RR, et al. 1991. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351:714-18
18. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. 1992. Cloned and expressed macrophage nitric oxide synthase contrasts with brain enzyme. Proc. Natl. Acad. Sci. USA 89:6711-15
19. Xie Q-W, Cho HJ. Calaycay J, Mumford RA. Swiderek KM, et al. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-28
20. Lyons CR, Orloff GJ, Cunninnham JM. 1992. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267:6370-74
21. Lamas S, Marsden PA, Li GK, Tempst P. Michel T. 1992. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA 89:6348-52
22. Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, et al. 1992. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J. Biol. Chem. 267: 15274-76
23. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. 1992. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267:14519-22
24. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M. et al. 1993. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 90:3491-95
25. Charles IG, Palmer MJ, Hickery MS, Bayliss MT, Chubb AP, et al. 1993. Cloning, characterization and expression of a cDNA encoding an inducible NO synthase from the human chondrocyte. Proc. Natl. Acad. Sci. USA 90:11419-23
26. Bredt DS, Ferris CD, Snyder SH. 1992. Nitric oxide synthase regulatory sites: phosphorylation by cyclic AMP dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J. Biol. Chem. 267:10976-81
27. Kwon NS, Nathan CF, Stuehr DJ. 1989. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J. Biol. Chem. 264: 20496-501
28. Tayeh MA, Marietta MA. 1989. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. J. Biol. Chem. 264:19654-58
29. Mayer B, John M, Heinzel B, Werner ER, Wachter H, et al. 1991. Brain nitric oxide synthase is a biopterin and flavincontaining multi-functional oxido-reductase. FEBS Lett. 288:187-91
30. McMillan K, Bredt DS, Hirsch DJ, Snyder SH, Clark JE, et al. 1992. Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme which bind carbon monoxide. Proc. Natl. Acad. Sci. USA 89:11141-45
31. Klatt P, Schmidt K, Mayer B. 1992. Brain nitric oxide synthase is a haemoprotein. Biochem. J. 288:15-17
32. Stuehr DJ, Ikeda-Saito M. 1992. Spectral characterization of brain and macrophage nitric oxide synthases. Cytochrome P-450-likc heme proteins that contain a flavin seniquinone radical. J. Biol. Chem. 267:20547-50
33. White LA, Marletta MA. 1992. Nitric oxide synthase is a cytochrome-P-450 like hemoprotein. Biochemistry 31: 6627-31
34. Wu W, Liuzzi FJ, Schinco FB, Depto A, Li Y, et al. 1994. Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury. Neuroscience 61:719-26
35. Verge VMK, Xu Z, Xu X-J, Wiesenfeld-Hallin Z, Hokfelt T. 1992. Marked increase in nitric oxide synthase mRNA in rat dorsal root ganglia after peripheral axotomy: in situ hybridization and functional studies. P roc. Natl. Acad. Sci. USA 89:11617-21
36. Cho HJ, Xie Q-W, Calaycay J, Mumford RA, Swiderek KM, et al. 1992. Calmodulin as a tightly bound subunit of calcium-, calmodulin-independent nitric oxide synthase. J. Exp. Med. 176:599-604
37. Nathan C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-64
38. Brüne B, Lapetina EG. 1991. Phosphorylation of nitric oxide synthase by protein kinase A. Biochem. Biophys. Res. Commun. 181:921-26
39. Nakane M, Mitchell J, Forstermann U, Murad F. 1991. Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem. Biophys. Res. Commun. 180: 1396-402
40. Bredt DS, Ferris CD, Snyder SH. 1992. Nitric oxide synthase regulatory sites. J. Biol. Chem. 267:10976-81
41. Dinerman JL, Snyder SH. 1994. Multiple phosphorylations of neuronal nitric oxide synthase inhibit catalytic activity. Neuropharmacology In press
42. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, et al. 1993. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon-gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90: 9730-34
43. Xie QW, Whisnant R, Nathan C. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by Interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-84
44. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, et al. 1991. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7:615-24
45. Hokfelt T, Johansson O, Ljungdahl A, Lundberg JM, Schultzberg M. 1980. Peptidergic neurons. Nature 284:515-21
46. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. 1991. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. USA 88:7797-801
47. Hirsch DB, Steiner JP, Dawson TM, Mammen A, Hayek E, et al. 1993. Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes. Curr. Biol. 3:749-54
48. Sandberg K, Berry CJ, Eugster E, Rogers TB. 1989. A role for cGMP during tetanus toxin blockade of acetylcholine release in the rat pheochromocytoma (PC12) cell lines. J. Neurosci. 9:3946-54
49. Sandberg K, Berry CJ, Rogers TB. 1989. Studies on the intoxication pathway of tetanus toxin in the rat pheochromocytoma (PC 12) cell line. J. Biol. Chem. 264:5679-86
50. Bredt DS, Hwang PM, Snyder SH. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-70
51. Boeckxstaens GE, Pelckmans PA, Bult H, DeMan JG, Herman AG. 1991. Evidence for nitric oxide as mediator of non-adrenergic non-cholinergic relaxations induced by ATP and GABA in the canine gut. Br. J. Pharmacol. 102: 434-38
52. Bull H, Boeckxstaens GE, Pelcknians PA, Jordaens FH, Van Maercke YM, et al. 1990. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 345:346-47
53. Desai KM, Sessa WC, Vane JR. 1991. Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 351:477-79
54. Tottrup A, Svane D, Forman A. 1991. Nitric oxide mediating NANC inhibition in opossum lower esophageal sphincter. Am. J. Physiol. 260:G385-89
55. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. 1993. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-86
56. Vanderwinden J-M. Mailleux P, Schiffmann SN, Vanderhaeghen J.J. DeLaet MH. 1992. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. New Engl. J. Med 327.8:511-15
57. Yamamoto R, Bredt DS, Snyder SH, Stone RA. 1993. The localization of nitric oxide synthase in the rat eye and related cranial ganglia. Neuroscience 54:189-200
58. Nozaki K, Moskowitz MA, Maynard KI, Koketsu N, Dawson TM, et al. 1993. Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in rat and human cerebral arteries. J. Cereb. Blood Flow Metab. 13:70-79
59. Burnett AL, Lowenstein CJ, Bredt DS, Chang TSK, Snyder SH, 1992. Nitric oxide: a physiologic mediator of penile erection. Science 257:401-3
60. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. 1992. Nitric oxide as a mediator of the corpus cavemosum in response to nonadrenergic noncholinergic transmission. New Engl. J. Med 326:90-94
61. Breslow MJ, Tobin JR, Bredt DS, Ferris CD, Snyder SH, et al. 1992. Role of nitric oxide in adrenal medullary vasodilation during catecholamine secretion. Eur. J. Pharmac. 87:682-85
62. Schuman EM, Madison DV. 1991. The intercellular messenger nitric oxide is required for long-term potentiation. Science 254:1503-6
63. Bohme GA, Bon C, Stutzmann J-M, Doble A, Blanchard J-C. 1991. Possible involvement of nitric oxide in long-term potentiation. Eur. J. Pharmac. 199:379-81
64. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O. 1991. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. USA 88:11285-89
65. Haley JE, Wilcox GL, Chapman PF. 1992. The role of nitric oxide in hippocampal long-term potentiation. Neuron 8:211-16
66. O'Dell TJ, Huang PL, Dawson TM, Dinerman JL, Snyder SH, et al. 1994. Endothelial NOS and the blockade of LTP by NOS inhibiters in mice lacking neuronal NOS. Science 265:542-46
67. Dinerman JL, Dawson TM, Schell MJ, Snowman A, Snyder SH. 1994. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. Natl. Acad. Sci. USA 91:4214-18
68. Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HHHW, et al. 1991. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88:10480-84
69. Busconi L, Michel T. 1993. Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J. Biol. Chem. 268:8410-13
70. Bredt DS, Snyder SH. 1994. Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory neurons. Neuron 13:301-13
71. Hess DT, Patterson SI, Smith DS, Pate Skene JH. 1993. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 366:562-65
72. Herdegen T, Brecht S, Mayer B, Leah J, Kummer W, et al. 1993. Long-lasting expression of JUN and KROX transcription factors and nitric oxide synthase in intrinsic neurons of the rat brain following axotomy. J. Neurosci. 13:4130-45
73. Kalb RG, Agostini J. 1993. Molecular evidence for nitric oxide-mediated motor neuron development. Neuroscience 57:1-8
74. Wu W, Li L. 1993. Inhibition of nitric oxide synthase reduces motoneuron death due to spinal root avulsion. Neurosci. Lett. 153:121-24
75. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-34
76. Meldrum B, Garthwaite J. 1990. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:379-87
77. Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr. Bird ED, et al. 1985. Selective sparing of a class of striatal neurons in Huntington's disease. Science 230:561-63
78. Hyman BT, Marzloff K, Wenniger JJ, Dawson TM, Bredt DS, et al. 1992. Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann. Neurol. 32:818-20
79. Koh J-Y, Choi DW. 1988. Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-Diaphorase. J. Neurosci. 8:2153-63
80. Koh J-Y, Peters S, Choi DW. 1986. Neurons containing NADPH-Diaphorase are selectively resistant to quinolinate toxicity. Science 234:73-76
81. Uemura Y, Kowall NW, Beal MF. 1990. Selective sparing of NADPH-Diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann. Neurol. 27:620-25
82. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc. Natl. Acad. Sci. USA 88:6368-71
83. Dawson VL, Dawson TM, Hartley DA, Uhl GR, Snyder SH. 1993. Mechanisms of nitric oxide mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:2651-61
84. Buisson A, Plotkine M, Boulu RG. 1992. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischemia. Br. J. Pharmacol. 106:766-67
85. Nagafuji T, Matsui T, Koide T, Asano T. 1992. Blockade of nitric oxide formation by N-omega-L-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats. Neurosci. Lett. 147:159-62
86. Trifiletti RR. 1992. Neuroprotective effects of Ng-nitro-L-arginine in focal stroke in the 7-day-old rat. Eur. J. Pharmac. 218:197-98
87. Nishikawa T, Kirsch JR, Koehler RC, Bredt DS, Snyder SH, et al. 1993. Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats. Stroke 24:1717-24
88. Nowicki JP, Duval D, Poignet H, Scatton B. 1991. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmac. 204:339-40
89. Dawson DA, Kusumoto K, Graham DI, McCulloch J, Macrae IM. 1992. Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia. Neurosci. Lett 142:151-54
90. Yamamoto S, Golanov EV, Berger SB, Reis DJ. 1992. Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J. Cereb. Blood Flow Metab. 12:717-26
91. 90a. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, et al. 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265:1883-85
92. Lipton SA. 1991. Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury. Ann. Neurol. 30:110-14
93. Dawson VL, Dawson TM, Uhl GR, Snyder SH. 1993. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA 90:3256-59
94. Lipton SA. 1992. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuro-Report 3:913-15
95. Manev H, Favaron M, Vicini S, Guidotti A, Costa E. 1990. Glutamate induced neuronal death in primary cultures of cerebellar granule cells: protection by synthetic derivatives of endogenous sphingolipids. J. Pharmacol. Exp. Ther. 252:419-27
96. Geisler FH, Dorsey FC, Coleman WP. 1992. GM-1 Ganglioside in human spinal cord injury. J. Neurotrauma 9:S517-30
97. Mahadik Sahebarao P. 1992. Gangliosides: new generation of neuroprotective agents. In Emerging Strategics in Neuroprotection, ed. PJ Malangos, H Lal, pp. 187-223. Boston: Birkhäuser
98. Skaper SD, Leon A. 1992. Monosialogangliosides, neuroprotection, and neuronal repair processes. J. Neurotrauma 9:S506-16
99. Higashi H, Omori A, Yamagata T. 1992. Calmodulin, a ganglioside-binding protein. Binding of gangliosides to calmodulin in the presence of calcium. J. Biol. Chem. 267:9831-38
100. Higashi H, Yamagata T. 1992. Mechanism for ganglioside-mediated modulation of a calmodulin-dependent enzyme. Modulation of calmodulin-dependent cyclic nucleotide phosphodiesterase activity through binding of gangliosides to calmodulin and the enzyme. J. Biol. Chem. 267:9839-43
101. Dawson TM, Hung K, Dawson VL, Steiner JP, Snyder SH. 1994. Neuro-protective effects of gangliosides may involve inhibition of nitric oxide synthase. Ann. Neurol. In press
102. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, et al. 1993. Immunosuppressant, FK506, enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. USA 90:9808-12
103. Lopez OL, Martinez AJ, Torre-Cisneros J. 1991. Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK506. Transplant Proc. 23:3181-82
104. 102a. Sharkey J, Butcher SP. 1994. Immunophilins mediate the neuroprotective effects of FK506 in local cerebral ischemia. Nature 371:336-39
105. Lustig HS, von Brauchitsch KL, Chan J, Greenberg DA 1992. Cyclic GMP modulators and excitotoxic injury in cerebral cortical cultures. Brain Res. 577:343-46
106. Hibbs JB Jr, Taintor RR, Vavrin V, Granger DL, Drapier J-C, et al. 1990. Synthesis of nitric oxide from a guanidino nitrogen of L-arginine: a molecular mechanism that targets intracellular iron. In Nitric Oxide from L-Arginine: A Bioregulatory System, ed. S Moncada, EA Higgs, pp. 189-223. Amsterdam: Elsevier
107. Reif DW, Simmons RD. 1990. Nitric oxide mediates iron release from ferritin. Arch. Biochem. Biophys. 283:537-41
108. Lepoivre M, Chenais B, Yapo A, Lemaire G. 1990. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J. Biol. Chem. 265:141-43
109. Kwon NS, Stuehr DJ, Nathan CF. 1991. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174:761-68
110. Klausner RD, Rouault TA, Harford JB. 1993. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72:19-28
111. Munro H. 1993. The ferritin genes: their response to iron status. Nutrition Rev. 51:65-73
112. Drapier JC, Hirling H, Weitzerbin J, Kaldy P, Kühn L. 1993. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J. 12:3643-49
113. Weiss G, Goossen B, Doppler W, Fuchs D, Pantopoulos K, et al. 1993. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J. 12:3651-57
114. Jaffrey SR, Cohen NA, Rouault TA, Klausner RD, Snyder SH. 1994. The iron-responsive element binding protein: a novel target for synaptic actions of nitric oxide. Proc. Natl. Acad. Sci. USA In press
115. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, et al. 1992. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA 89:444-48
116. Stamler JS, Singel DJ, Loscalzo J. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898-902
117. Kots AY, Skurat AV, Sergienko EA, Bulargina TV. Severin ES. 1992 Nitroprusside stimulates the cysteine-specific mono(ADP-ribosylation) of glyceraldehyde-3-phosphate dehydrogenase from human erythrocytes. FEBS Lett. 300:9-12
118. Dimmeler S, Lottspeich F, Brüne B. 1992. Nitric oxide causes ADP-ribosylalion and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 267:16771-74
119. Zhang J, Snyder SH. 1992. Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. USA 89:9382-85
120. Dimmeler S, Brüne B. 1992. Characterization of a nitric-oxide-catalysed ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Eur. J. Biochem. 210:305-10
121. McDonald LJ, Moss J. 1993. Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. USA 90:6238-41
122. DeMattis MA, DiGirolamo M, Colanzi A, Pallas M, DiTullio G, et al. 1994. Stimulation of endogenous ADP-ribosylation by brefeldin A. Proc. Natl. Acad. Sci. USA 91:1114-18
123. Molina y Vedia L, McDonald B, Reep B, Brüne B, DiSilvio M, et al. 1992. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol. Chem. 267:24929-32
124. Brumley LM, Beckman JS, Friedlander MJ, Marchase RB. 1993. Peroxynitrite but not nitric oxide interacts with glyceraldehyde-3-phosphate dehydrogenase. Mol. Biol Cell 4:72a
125. Dimmeler S, Ankarcrona M, Nicotera P, Brüne B. 1993. Exogenous nitric oxide (NO) generation or IL-1β-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells. J. Immunol. 150:2964-71
126. Zhang J, Dawson VL, Dawson TM, Snyder SH. 1994. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 263:687-89
127. de Murcia G, Menissier-de Murcia J, Schreiber V. 1991. Poly(ADP-ribose) polymerase: molecular biological aspects. BioEssays 13:455-62
128. Miller MS, Zobre C, Lewis M. 1993. In vitro neuroprotective activity of inhibitors of poly-ADP-ribose polymerase. Soc. Neurosci. Abstr. 19:1656
129. Wallis RA, Panizzon KL, Henry D, Wasterlain CG. 1993. Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation. Neuropharmacol. Neurotoxicol. 5:245-48
130. Kroncke K-D, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H. 1991. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun. 175:752-58
131. Kallman B, Burkart V, Kroncke K-D, Kolb-Bachofen V, Kolb H. 1992. Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci. 51: 671-78
132. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, et al. 1993. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90:7240-44
133. Rettori M, Gimeno M, Lyson K, McCann SM. 1992. Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus. Proc. Natl. Acad. Sci. USA 89:11543-46
134. Karanth S, Lyson K, McCann SM. 1993. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc. Natl. Acad. Sci. USA 90:3383-87
135. Corbett JA, Kwon G, Turk J, McDaniel ML. 1993. IL-β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry 32:13767-70
136. Khatsenko OG, Gross SS, Rifkind AB, Vane JR. 1993. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. USA 90:11147-51
137. Stadler J, Trockfeld J, Schmalix WA, Brill T, Siewert R, et al. 1994. Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. USA 91:3559-63
138. Lei SZ, Pan ZH, Aggarwal SK, Chen HSV, Hartman J, et al. 1992. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8:1087-99
139. Gopalakrishna R, Chen ZH, Gundimeda U. 1993. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J. Biol. Chem. 268:27180-85
140. Tang YG, Zheng YF. 1993. Ertdothelium-derived relaxing factor activates calcium-activated potassium channels of resistance vessel smooth muscle cells. Sci. China B 36:439-50
141. + channels in vasodilation induced by nitroglycerine, acetylcholine and nitric oxide. J. Pharmacol. Exp. Ther. 267:1327-35
142. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. 1994. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368:850-53
143. Lander HM, Sehajpal P, Levine DM, Novogrodsky A. 1993. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1509-16
144. Lander HM, Sehajpal PK, Novogrodsky A. 1993. Nitric oxide signaling: a possible role for G proteins. J. Immunol. 151:7182-87
145. Stamler JS, Jaraki O, Osborne J, Simon DL, Keaney J, et al. 1992. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA 89:7674-77
146. Clancy RM, Levartoxsky D, Leszczynska-Piziak J, Yegudin J, Abramson SB. 1994. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl. Acad. Sci. USA 91:3680-84
147. Beckman JS, Carson M, Smith CD, Koppenol WH. 1993. ALS, SOD and peroxynitrite. Nature 364:584
148. Hogg N, Darby-Usman VM, Wilson MT, Moncada S. 1993. The oxidation of alpha-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. FEBS Lett. 326:199-203
149. King PA, Anderson VE, Edwards JO, Gustafson G, Plumb RC, et al. 1992. A stable solid that generates hydroxyl radical upon dissolution in aqueous solutions: reaction with proteins and nucleic acid. J. Am. Chem. Soc. 114:5430-32
150. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, et al. 1992. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA 89:3030-34